We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-12.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.1B
AUM Growth
-$2.55B
(-17%)
Cap. Flow
-$469M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
25.18%
Holding
858
New
52
Increased
315
Reduced
272
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$38.7M |
| 2 |
Apple
AAPL
|
+$27.7M |
| 3 |
Salesforce
CRM
|
+$26.1M |
| 4 |
Verizon
VZ
|
+$25.9M |
| 5 |
PepsiCo
PEP
|
+$24.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.7M |
| 2 |
Waste Management
WM
|
+$64.8M |
| 3 |
Sociedad Química y Minera de Chile
SQM
|
+$58.6M |
| 4 |
Citigroup
C
|
+$56.5M |
| 5 |
Johnson & Johnson
JNJ
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.24% |
| 2 | Technology | 24.24% |
| 3 | Financials | 8.36% |
| 4 | Communication Services | 6.82% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Paychex
PAYX
$41.1B
| $4.06M | 0.03% |
35,659
-9,644
| -21% | -$1.21M |
|
352
Lam Research
LRCX
$365B
| $4.04M | 0.03% |
94,820
+3,330
| +4% | +$159K |
|
353
Fidelity National Information Services
FIS
$22.3B
| $4.04M | 0.03% |
44,040
-1,057
| -2% | -$105K |
|
|
INBX
354
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $4M | 0.03% |
352,069
+84,632
| +32% | +$1.25M |
|
|
SWTX
355
DELISTED
SpringWorks Therapeutics
SWTX
| $3.99M | 0.03% |
162,109
| – | – |
|
356
Dropbox
DBX
$7.13B
| $3.98M | 0.03% |
189,669
-36,807
| -16% | -$796K |
|
357
Avery Dennison
AVY
$12.5B
| $3.96M | 0.03% |
24,466
| – | – |
|
358
Zurn Elkay Water Solutions
ZWS
$8.14B
| $3.93M | 0.03% |
+144,164
| New | +$4.37M |
|
359
Genmab
GMAB
$17.7B
| $3.91M | 0.03% |
120,424
-36,978
| -23% | -$1.2M |
|
360
Allstate
ALL
$67.3B
| $3.91M | 0.03% |
30,863
-1,620
| -5% | -$212K |
|
361
Centene
CNC
$31.6B
| $3.88M | 0.03% |
45,918
+8,514
| +23% | +$707K |
|
362
Cummins
CMI
$91.3B
| $3.88M | 0.03% |
20,030
| – | – |
|
363
Motorola Solutions
MSI
$70.3B
| $3.87M | 0.03% |
18,473
-53,634
| -74% | -$11.7M |
|
364
Northern Trust
NTRS
$22.4B
| $3.75M | 0.03% |
38,828
+957
| +3% | +$101K |
|
365
US Bancorp
USB
$98.9B
| $3.73M | 0.03% |
81,163
-4,885
| -6% | -$244K |
|
366
Norfolk Southern
NSC
$77.1B
| $3.71M | 0.03% |
16,343
-1,974
| -11% | -$485K |
|
367
Pinduoduo
PDD
$121B
| $3.71M | 0.03% |
60,000
+43,263
| +258% | +$2.03M |
|
368
Eversource Energy
ES
$28.1B
| $3.7M | 0.03% |
43,792
-5
| -0% | -$444 |
|
369
Akamai
AKAM
$16.4B
| $3.66M | 0.03% |
40,073
+5,135
| +15% | +$535K |
|
|
ATVI
370
DELISTED
Activision Blizzard
ATVI
| $3.65M | 0.03% |
46,878
-248,226
| -84% | -$19.3M |
|
371
BridgeBio Pharma
BBIO
$16.5B
| $3.65M | 0.03% |
401,912
| – | – |
|
372
Nucor
NUE
$56.4B
| $3.62M | 0.03% |
34,703
-101,815
| -75% | -$13.8M |
|
373
Kimberly-Clark
KMB
$37B
| $3.6M | 0.03% |
24,418
+1,455
| +6% | +$192K |
|
374
Zentalis Pharmaceuticals
ZNTL
$321M
| $3.6M | 0.03% |
127,973
| – | – |
|
375
Cheniere Energy
LNG
$53.6B
| $3.59M | 0.03% |
26,985
-4,038
| -13% | -$550K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2022 Portfolio in Review
As of Q2 2022, Candriam SCA held 858 positions worth $12.1B, down 17% from $14.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Candriam SCA withdrew a net $469M in Q2 2022, closing 83 positions and reducing 272 holdings. Its most notable exit was TriState Capital Holdings, Inc., an estimated $20.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Tenable Holdings worth $16.3M.
- Candriam SCA's largest Q2 2022 buy was Tenable Holdings: 359,981 shares worth $16.3M.
- Candriam SCA added most to Procter & Gamble in Q2 2022, an estimated $38.7M increase.
- Candriam SCA's biggest Q2 2022 reduction was Microsoft, cutting an estimated $65.7M.
- Candriam SCA fully exited TriState Capital Holdings, Inc. in Q2 2022, selling an estimated $20.9M.
- Candriam SCA's ten largest holdings make up 25% of its $12.1B portfolio in Q2 2022.
- Candriam SCA opened 52 new positions and closed 83 in Q2 2022.
- Candriam SCA's portfolio value fell 17% quarter-over-quarter to $12.1B.
Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.